Startups
The Investor Relations website contains information about Exagen's business for stockholders, potential investors, and financial analysts.
Overview
Phone
+1 888-452-1522
Mentions in press and media 23
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Aug 7, 2023 | Exagen Inc. Reports Strong Second Quarter 2023 Results | SAN DIEGO, Aug. 07, 2023 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended June 30, 2023. |
| May 15, 2023 | Exagen Inc. Reports First Quarter 2023 Results | Record Physician Demand for AVISE® CTD |
| Mar 20, 2023 | Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results | Record AVISE® CTD Volume in 2022 |
| Nov 14, 2022 | Exagen Inc. Reports Third Quarter 2022 Results | Medicare Reimbursement Returns |
| Aug 4, 2022 | Exagen Inc. Reports Second Quarter 2022 Results | Records in AVISE® CTD Volume, Ordering Healthcare Providers and Adopters |
| May 11, 2022 | Exagen Inc. Reports First Quarter 2022 Results | Records in Ordering Healthcare Providers and Adopters, Set All-Time Record for AVISE® CTD Monthly Volume in March |
| Mar 22, 2022 | Exagen Inc. Reports Fourth Quarter and Full Year 2021 Results | Six Quarterly Records: AVISE® CTD Volume, Testing Revenue, Testing Gross Margin, Testing Gross Margin Percent, Adopters, and Ordering Healthcare Providers |
| Nov 11, 2021 | Exagen Inc. Reports Third Quarter 2021 Results - Form 8-K | Exagen Inc. Reports Third Quarter 2021 Results Quarterly Records: Ordering Healthcare Providers and Adopters November 10, 2021 SAN DIEGO - Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financi... |
| Nov 11, 2021 | Exagen Inc. Reports Third Quarter 2021 Results | SAN DIEGO, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2021. Third Quarter Highlights: Generated total... |
Show more